Market Forecast by Countries (Brazil, Mexico, Argentina, Rest of Latin America), By Origin (Human Primary Cells, Animal Primary Cells), By Type (Hematopoietic Cells, Dermatocytes, Gastrointestinal Cells, Hepatocytes, Lung Cells, Renal Cells, Heart Cells, Other), By End User (Life Science Research Companies, Research Institutes) And Competitive Landscape
Product Code: ETC059094 | Publication Date: May 2021 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 200 | No. of Figures: 90 | No. of Tables: 30 |
Latin America Primary Cell Market is estimated to register sound revenue in the coming timeframe backed by increased product use by biotechnology companies in the developed and developing nation across the region along with the rise in the ongoing research for cancer and the progress of its treatment. Moreover, the growing number of research institutes where 3D cell culture is estimated to hold a large market share owing to the rising use of primary cells in multiple studies such as the research of ageing process, study about the effects of the drugs, the study of signalling, and metabolic regulations is estimated to instigate the demand for primary cells and is further expected to boost the growth of the Latin America primary cell market in the coming timeframe. Also, cells extracted and isolated directly from the living tissue or organ are known as primary cells. Primary cells are obtained from both human and animal living tissues. These cells are the perfect samples for cancer biomarker discovery and drug screening. They are also used to understand the biochemical pathways of cellular interactions. Additionally, the research departments are surging their preference for the primary cells of the immune system to research coupled with the development and implementation of new drug acts.
According to 6Wresearch, Latin America Primary Cell Market size is anticipated to register growth during 2021-2027. Contamination of the cells in laboratories is one of the key restrictions in the primary cells market across the region. This contamination of cell not only jeopardizes the cell physiology but also cause the loss of unique cell lines. Furthermore, this leads to slow down the cell metabolism eventually affecting the final results of the products such as vaccines, which can destroy the entire batch. Due to this, companies limit their investments in cell-based research and consider alternative methods for drug screening. The economic and social burden of the COVID-19 pandemic has prompted government bodies globally to increase support for vaccine development, which has led to an increase in the adoption rates of primary cells for the research. The WHO has declared the outbreak a pandemic and has increased funding for research into the virus. In 2019, Latin America accounted for the biggest share within the primary cells market. Due to this, the expansion within the Latin America primary cells market is credited for increasing various competitors for launching new human primary cells for analysis, enlargement of the pharmaceutical and biotechnology industries, growing to specialize in R&D, and increasing prevalence of cancer within the region.
In terms of end-users, the life science research companies segment accounted for the largest share of the primary cells market in 2019. The increasing adoption of human primary cells in the development of advanced cancer therapies and the raising funding for the R&D for cell therapies are the major factors driving the growth of this segment. Based on type, the primary cells market is segmented into hematopoietic cells, gastrointestinal cells, hepatocytes, lung cells, renal cells, heart cells, musculoskeletal cells, and other primary cells. As a result, this segment reported the largest market share. In cancer research, primary cells are often exposed to heavy radiation doses, chemicals, and viruses, which transform these cells into cancer cells through genetic mutations and the introduction of oncogenes. Opportunities such as the adoption of primary cells in 3D cultures are high due to their more accurate outcomes as compared to normal cell lines. For example, primary hepatocytes cells, when cultured as a monolayer on plastic, become undifferentiated and die within four days. Primary liver cells are more accurate models of in vitro multicellular environments as compared with normal cell lines in the market.
The key players in this Latin America primary cell market are Thermo Fisher Scientific, Inc. (the US), Merck KGaA (Middle East), Lonza (Switzerland), Cell Biologics, Inc. (the US), PromoCell GmbH (Middle East), HemaCare Corporation (US), ZenBio, Inc. (the US), STEMCELL Technologies, Inc. (Canada), Corning Incorporated (US), AllCells (US), American Type Culture Collection (US), Axol Bioscience Ltd. (UK), iXCells Biotechnologies (US), Neuromics (US), StemExpress (US), BioIVT (US), ScienCell Research Laboratories, Inc. (the US), PPA Research Group, Inc. (US), Creative Bioarray (US), BPS Bioscience, Inc. (US), Epithelix Sร rl (Switzerland), ReachBio LLC (US), AcceGen (US), Sekisui XenoTech, LLC (US), and Biopredic International (Latin America).
Latin America primary cell market report thoroughly covers the market by type, origin, end-user, and countries including Mexico, Brazil, Argentina, Chile, and the rest of Latin America. Latin America primary cell Market outlook report provides an unbiased and detailed analysis of the ongoing Latin America primary cell market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
Markets Covered
The Market report includes the following segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latin America Primary Cell Market Overview |
3.1 Latin America Regional Macro Economic Indicators |
3.2 Latin America Primary Cell Market Revenues & Volume, 2020 & 2027F |
3.3 Latin America Primary Cell Market - Industry Life Cycle |
3.4 Latin America Primary Cell Market - Porter's Five Forces |
3.5 Latin America Primary Cell Market Revenues & Volume Share, By Countries, 2020 & 2027F |
3.6 Latin America Primary Cell Market Revenues & Volume Share, By Origin, 2020 & 2027F |
3.7 Latin America Primary Cell Market Revenues & Volume Share, By Type, 2020 & 2027F |
3.8 Latin America Primary Cell Market Revenues & Volume Share, By End User, 2020 & 2027F |
4 Latin America Primary Cell Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Latin America Primary Cell Market Trends |
6 Latin America Primary Cell Market, 2017 - 2027 |
6.1 Latin America Primary Cell Market, Revenues & Volume, By Origin, 2017 - 2027 |
6.2 Latin America Primary Cell Market, Revenues & Volume, By Type, 2017 - 2027 |
6.3 Latin America Primary Cell Market, Revenues & Volume, By End User, 2017 - 2027 |
7 Brazil Primary Cell Market, 2017 - 2027 |
7.1 Brazil Primary Cell Market, Revenues & Volume, By Origin, 2017 - 2027 |
7.2 Brazil Primary Cell Market, Revenues & Volume, By Type, 2017 - 2027 |
7.3 Brazil Primary Cell Market, Revenues & Volume, By End User, 2017 - 2027 |
8 Mexico Primary Cell Market, 2017 - 2027 |
8.1 Mexico Primary Cell Market, Revenues & Volume, By Origin, 2017 - 2027 |
8.2 Mexico Primary Cell Market, Revenues & Volume, By Type, 2017 - 2027 |
8.3 Mexico Primary Cell Market, Revenues & Volume, By End User, 2017 - 2027 |
9 Argentina Primary Cell Market, 2017 - 2027 |
9.1 Argentina Primary Cell Market, Revenues & Volume, By Origin, 2017 - 2027 |
9.2 Argentina Primary Cell Market, Revenues & Volume, By Type, 2017 - 2027 |
9.3 Argentina Primary Cell Market, Revenues & Volume, By End User, 2017 - 2027 |
10 Rest of Latin America Primary Cell Market, 2017 - 2027 |
10.1 Rest of Latin America Primary Cell Market, Revenues & Volume, By Origin, 2017 - 2027 |
10.2 Rest of Latin America Primary Cell Market, Revenues & Volume, By Type, 2017 - 2027 |
10.3 Rest of Latin America Primary Cell Market, Revenues & Volume, By End User, 2017 - 2027 |
11 Latin America Primary Cell Market Key Performance Indicators |
12 Latin America Primary Cell Market - Opportunity Assessment |
12.1 Latin America Primary Cell Market Opportunity Assessment, By Countries, 2020 & 2027F |
12.2 Latin America Primary Cell Market Opportunity Assessment, By Origin, 2020 & 2027F |
12.3 Latin America Primary Cell Market Opportunity Assessment, By Type, 2020 & 2027F |
12.4 Latin America Primary Cell Market Opportunity Assessment, By End User, 2020 & 2027F |
13 Latin America Primary Cell Market - Competitive Landscape |
13.1 Latin America Primary Cell Market Revenue Share, By Companies, 2020 |
13.2 Latin America Primary Cell Market Competitive Benchmarking, By Operating and Technical Parameters |
14 Company Profiles |
15 Recommendations |
16 Disclaimer |